TIVC logo

TIVC
Tivic Health Systems Inc

4,616
Mkt Cap
$2.96M
Volume
27,899.00
52W High
$5.60
52W Low
$0.7217
PE Ratio
-0.11
TIVC Fundamentals
Price
$1.02
Prev Close
$1.03
Open
$1.03
50D MA
$0.9808
Beta
1.24
Avg. Volume
208,475.57
EPS (Annual)
-$7.58
P/B
0.31
Rev/Employee
$0.00
$2.85
Loading...
Loading...
News
all
press releases
Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening
Tivic Health Systems Inc. shares rise 24.10% after hours after announcing a full rebrand to Valion Bio and a strategic pivot toward Entolimod-based immunotherapy development.read more...
Benzinga·13d ago
News Placeholder
More News
News Placeholder
Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model
Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model...
PR Newswire·14d ago
News Placeholder
Sheryle Bolton Purchases 10,000 Shares of Tivic Health Systems (NASDAQ:TIVC) Stock
Tivic Health Systems, Inc. (NASDAQ:TIVC - Get Free Report) Director Sheryle Bolton acquired 10,000 shares of Tivic Health Systems stock in a transaction on Wednesday, April 15th. The shares were...
MarketBeat·16d ago
News Placeholder
Tivic Health Selected to Present Entolimod as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th
Tivic Health Selected to Present Entolimod as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th Tivic Health Selected to...
PR Newswire·22d ago
News Placeholder
Tivic Health Systems (NASDAQ:TIVC) Director Christina Rizopoulos Valauri Acquires 19,000 Shares
Tivic Health Systems, Inc. (NASDAQ:TIVC - Get Free Report) Director Christina Rizopoulos Valauri purchased 19,000 shares of Tivic Health Systems stock in a transaction dated Wednesday, April 1st. The shares were purchased at an average cost of $0.95 per share, for a total transaction of $18,050.00...
MarketBeat·1mo ago
News Placeholder
Tivic Expands Intellectual Property Portfolio
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced it is expanding its intellectual property portfolio with the recent filing of two additional patent...
Business Wire·6mo ago
News Placeholder
Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and...
Business Wire·6mo ago
News Placeholder
Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global...
Business Wire·7mo ago
News Placeholder
Tivic Receives Two Investigational New Drug Applications for Entolimod for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational new drug applications (INDs) for its...
Business Wire·9mo ago
News Placeholder
Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025...
Business Wire·9mo ago
<
1
2
...
>

Latest TIVC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.